z-logo
Premium
Suspected infections in children treated for ALL
Author(s) -
Hafsteinsdóttir Sólveig,
Jónasson Kristján,
Jónmundsson Guðmundur K,
Kristinsson Jón R,
Jónsson Ólafur Gísli,
Alfreðsdóttir Inga Huld,
Cilio Corrado,
Wiebe Thomas,
Haraldsson Ásgeir
Publication year - 2009
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2009.01286.x
Subject(s) - medicine , epidemiology , pediatrics , coagulase , staphylococcus aureus , staphylococcus , bacteria , biology , genetics
Aim:  The aim of our study was to get epidemiological information on bacterial infections in children treated for ALL and to analyse which patients have an enhanced infection risk. Methods:  Episodes of suspected or confirmed infections were evaluated during the first 12 months of treatment for childhood acute lymphoblastic leukaemia (ALL). Results:  The number of patients was 73 (43 boys). The median age was 4.6 years. A total of 179 episodes occurred, varying from none in six patients to eight in one. Bacteria were cultured in 57 episodes (31.8%), the most common being coagulase‐negative staphylococci. The number of episodes fell significantly with increasing age for suspected and confirmed infections (p < 0.001 and p = 0.03). The proportion of confirmed infections was significantly higher (p < 0.001) in the first episodes. The average number of suspected infections was higher in girls than in boys (p = 0.03), but confirmed infections were not. Conclusion:  Most of the serious infections occur early in the treatment and the number of suspected and confirmed infections falls with age. Suspicion of infection is more likely in girls, but the number of confirmed infections is equal in both sexes. Coagulase‐negative staphylococcus was most commonly isolated, highlighting the importance of careful handling of central venous devices.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here